These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bermuda
|
77-0553536
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification Number)
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
Page
|
|
Part I.
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 3.
|
||
|
Item 4.
|
||
|
Part II.
|
OTHER INFORMATION
|
|
|
Item 1.
|
||
|
Item 1A.
|
Risk Factors
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
Item 3.
|
Defaults Upon Senior Securities
|
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
Item 5.
|
Other Information
|
|
|
Item 6.
|
Exhibits
|
|
|
ALPHA AND OMEGA SEMICONDUCTOR LIMITED
|
|||||||
|
|
|||||||
|
(Unaudited, in thousands except par value per share)
|
|||||||
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
95,198
|
|
|
$
|
82,166
|
|
|
Restricted cash
|
239
|
|
|
236
|
|
||
|
Accounts receivable, net
|
29,378
|
|
|
38,850
|
|
||
|
Inventories
|
71,056
|
|
|
65,778
|
|
||
|
Deferred income tax assets
|
2,803
|
|
|
2,789
|
|
||
|
Other current assets
|
2,687
|
|
|
3,962
|
|
||
|
Total current assets
|
201,361
|
|
|
193,781
|
|
||
|
Property, plant and equipment, net
|
157,010
|
|
|
158,543
|
|
||
|
Intangible assets, net
|
885
|
|
|
1,028
|
|
||
|
Goodwill
|
269
|
|
|
269
|
|
||
|
Deferred income tax assets
|
10,234
|
|
|
10,061
|
|
||
|
Other long-term assets
|
967
|
|
|
2,475
|
|
||
|
Total assets
|
$
|
370,726
|
|
|
$
|
366,157
|
|
|
|
|
|
|
||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Short term debt
|
$
|
3,571
|
|
|
$
|
3,571
|
|
|
Accounts payable
|
32,601
|
|
|
35,646
|
|
||
|
Accrued liabilities
|
18,570
|
|
|
21,026
|
|
||
|
Income taxes payable
|
2,685
|
|
|
2,349
|
|
||
|
Deferred margin
|
393
|
|
|
366
|
|
||
|
Capital leases - current portion
|
949
|
|
|
961
|
|
||
|
Total current liabilities
|
58,769
|
|
|
63,919
|
|
||
|
Long term debt
|
15,964
|
|
|
16,429
|
|
||
|
Income taxes payable - long term
|
3,627
|
|
|
3,509
|
|
||
|
Deferred income tax liabilities
|
1,091
|
|
|
587
|
|
||
|
Capital leases - long term
|
847
|
|
|
1,085
|
|
||
|
Deferred rent
|
1,286
|
|
|
1,235
|
|
||
|
Total liabilities
|
81,584
|
|
|
86,764
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies (Note 10)
|
|
|
|
||||
|
Shareholders' equity:
|
|
|
|
||||
|
Preferred shares, par value $0.002 per share:
|
|
|
|
||||
|
Authorized: 10,000 shares; Issued and outstanding: none at September 30, 2012 and June 30, 2012
|
—
|
|
|
—
|
|
||
|
Common shares, par value $0.002 per share:
|
|
|
|
||||
|
Authorized: 50,000 shares; Issued and outstanding: 25,314 shares and 25,085 shares at September 30, 2012 and 25,167 shares and 24,938 shares at June 30, 2012
|
51
|
|
|
50
|
|
||
|
Treasury shares at cost; 229 shares at September 30, 2012 and June 30, 2012
|
(2,102
|
)
|
|
(2,104
|
)
|
||
|
Additional paid-in capital
|
162,477
|
|
|
160,602
|
|
||
|
Accumulated other comprehensive income
|
1,002
|
|
|
972
|
|
||
|
Retained earnings
|
127,714
|
|
|
119,873
|
|
||
|
Total shareholders’ equity
|
289,142
|
|
|
279,393
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
370,726
|
|
|
$
|
366,157
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
Revenue
|
$
|
95,761
|
|
|
$
|
83,448
|
|
|
Cost of goods sold
|
70,228
|
|
|
62,871
|
|
||
|
Gross profit
|
25,533
|
|
|
20,577
|
|
||
|
|
|
|
|
||||
|
Operating expenses:
|
|
|
|
||||
|
Research and development
|
6,933
|
|
|
8,394
|
|
||
|
Selling, general and administrative
|
8,781
|
|
|
9,283
|
|
||
|
Total operating expenses
|
15,714
|
|
|
17,677
|
|
||
|
Operating income
|
9,819
|
|
|
2,900
|
|
||
|
|
|
|
|
||||
|
Interest income
|
17
|
|
|
39
|
|
||
|
Interest expense
|
(82
|
)
|
|
(27
|
)
|
||
|
Income before income taxes
|
9,754
|
|
|
2,912
|
|
||
|
|
|
|
|
||||
|
Income tax expense
|
1,812
|
|
|
773
|
|
||
|
Net income
|
$
|
7,942
|
|
|
$
|
2,139
|
|
|
|
|
|
|
||||
|
Net income per share attributable to common shareholders
|
|
|
|
||||
|
Basic
|
$
|
0.32
|
|
|
$
|
0.09
|
|
|
Diluted
|
$
|
0.31
|
|
|
$
|
0.08
|
|
|
|
|
|
|
||||
|
Weighted average number of common shares used to compute net income per share
|
|
|
|
||||
|
Basic
|
25,038
|
|
|
24,472
|
|
||
|
Diluted
|
25,884
|
|
|
25,495
|
|
||
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
Net income
|
$
|
7,942
|
|
|
$
|
2,139
|
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
||||
|
Foreign currency translation adjustment
|
30
|
|
|
(11
|
)
|
||
|
Total comprehensive income
|
$
|
7,972
|
|
|
$
|
2,128
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
Cash flows from operating activities
|
|
|
|
||||
|
Net income
|
$
|
7,942
|
|
|
$
|
2,139
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation
|
7,180
|
|
|
5,707
|
|
||
|
Amortization
|
143
|
|
|
143
|
|
||
|
Allowance for doubtful accounts
|
—
|
|
|
60
|
|
||
|
Share-based compensation expense
|
1,441
|
|
|
1,222
|
|
||
|
Deferred income taxes, net
|
318
|
|
|
28
|
|
||
|
Loss on disposal of property and equipment
|
51
|
|
|
—
|
|
||
|
Changes in working capital:
|
|
|
|
||||
|
Accounts receivable
|
9,472
|
|
|
17,010
|
|
||
|
Inventories
|
(5,278
|
)
|
|
11,942
|
|
||
|
Other current and long term assets
|
2,784
|
|
|
575
|
|
||
|
Accounts payable
|
1,469
|
|
|
(22,166
|
)
|
||
|
Income taxes payable
|
455
|
|
|
(1,101
|
)
|
||
|
Accrued and other liabilities
|
(2,367
|
)
|
|
(3,618
|
)
|
||
|
Net cash provided by operating activities
|
$
|
23,610
|
|
|
$
|
11,941
|
|
|
|
|
|
|
||||
|
Cash flows from investing activities
|
|
|
|
||||
|
Purchases of property and equipment
|
(10,243
|
)
|
|
(12,568
|
)
|
||
|
Restricted cash released (placed)
|
(3
|
)
|
|
16
|
|
||
|
Investment in a privately held company
|
—
|
|
|
(100
|
)
|
||
|
Net cash used in investing activities
|
$
|
(10,246
|
)
|
|
$
|
(12,652
|
)
|
|
|
|
|
|
||||
|
Cash flows from financing activities
|
|
|
|
||||
|
Proceeds from exercise of share options
|
376
|
|
|
126
|
|
||
|
Payment for repurchase of common shares
|
—
|
|
|
(1,574
|
)
|
||
|
Proceeds from borrowings
|
250
|
|
|
4,002
|
|
||
|
Repayments of borrowings
|
(715
|
)
|
|
—
|
|
||
|
Principal payments on capital leases
|
(250
|
)
|
|
(145
|
)
|
||
|
Net cash provided by (used in) financing activities
|
$
|
(339
|
)
|
|
$
|
2,409
|
|
|
|
|
|
|
||||
|
Effect of exchange rate changes on cash and cash equivalents
|
7
|
|
|
(6
|
)
|
||
|
Net increase in cash and cash equivalents
|
13,032
|
|
|
1,692
|
|
||
|
Cash and cash equivalents at beginning of period
|
82,166
|
|
|
86,708
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
95,198
|
|
|
$
|
88,400
|
|
|
|
|
|
|
||||
|
Supplemental disclosures of non cash investing and financing information:
|
|
|
|
||||
|
Property and equipment purchased but not yet paid
|
$
|
3,963
|
|
|
$
|
10,875
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands, except per share data)
|
||||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
7,942
|
|
|
$
|
2,139
|
|
|
|
|
|
|
||||
|
Denominator:
|
|
|
|
||||
|
Basic:
|
|
|
|
||||
|
Weighted average number of common shares used to compute basic net income per share
|
25,038
|
|
|
24,472
|
|
||
|
Diluted:
|
|
|
|
||||
|
Effect of potentially dilutive securities:
|
|
|
|
||||
|
Stock options, RSUs and ESPP shares
|
846
|
|
|
1,023
|
|
||
|
Weighted average number of common shares used to compute diluted net income per share
|
25,884
|
|
|
25,495
|
|
||
|
Net income per share attributable to common shareholders:
|
|
|
|
||||
|
Basic
|
$
|
0.32
|
|
|
$
|
0.09
|
|
|
Diluted
|
$
|
0.31
|
|
|
$
|
0.08
|
|
|
|
Three Months Ended September 30,
|
||||
|
|
2012
|
|
2011
|
||
|
|
(in thousands)
|
||||
|
Employee stock options and RSUs
|
2,694
|
|
|
2,568
|
|
|
ESPP to purchase common shares
|
316
|
|
|
—
|
|
|
Total potential dilutive securities
|
3,010
|
|
|
2,568
|
|
|
|
Three Months Ended September 30,
|
||||
|
Percentage of revenue
|
2012
|
|
2011
|
||
|
Customer A
|
23.6
|
%
|
|
17.3
|
%
|
|
Customer B
|
41.5
|
%
|
|
44.9
|
%
|
|
Customer C
|
13.7
|
%
|
|
14.4
|
%
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||
|
Percentage of accounts receivable
|
|
||||
|
Customer A
|
19.8
|
%
|
|
34.1
|
%
|
|
Customer B
|
14.2
|
%
|
|
23.6
|
%
|
|
Customer C
|
31.7
|
%
|
|
20.4
|
%
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
Accounts receivable
|
$
|
46,620
|
|
|
$
|
55,858
|
|
|
Less: Allowance for price adjustments
|
(16,490
|
)
|
|
(16,256
|
)
|
||
|
Less: Allowance for doubtful accounts
|
(752
|
)
|
|
(752
|
)
|
||
|
Accounts receivable, net
|
$
|
29,378
|
|
|
$
|
38,850
|
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
Raw materials
|
$
|
27,115
|
|
|
$
|
27,856
|
|
|
Work in-process
|
33,497
|
|
|
28,188
|
|
||
|
Finished goods
|
10,444
|
|
|
9,734
|
|
||
|
|
$
|
71,056
|
|
|
$
|
65,778
|
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
Land
|
$
|
4,950
|
|
|
$
|
4,950
|
|
|
Building
|
4,106
|
|
|
4,077
|
|
||
|
Manufacturing machinery and equipment
|
156,908
|
|
|
152,307
|
|
||
|
Equipment and tooling
|
9,861
|
|
|
9,910
|
|
||
|
Computer equipment and software
|
14,669
|
|
|
14,912
|
|
||
|
Office furniture and equipment
|
1,551
|
|
|
1,630
|
|
||
|
Leasehold improvements
|
22,669
|
|
|
22,463
|
|
||
|
|
214,714
|
|
|
210,249
|
|
||
|
Less accumulated depreciation
|
(69,644
|
)
|
|
(63,114
|
)
|
||
|
|
145,070
|
|
|
147,135
|
|
||
|
Equipment and construction in progress
|
11,940
|
|
|
11,408
|
|
||
|
Property, plant and equipment, net
|
$
|
157,010
|
|
|
$
|
158,543
|
|
|
|
|
|
|
||||
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
Prepayments for property and equipment
|
$
|
167
|
|
|
$
|
1,632
|
|
|
Investment in a privately held company
|
100
|
|
|
100
|
|
||
|
Deferred debt issuance cost
|
173
|
|
|
204
|
|
||
|
Office leases deposits
|
527
|
|
|
539
|
|
||
|
|
$
|
967
|
|
|
$
|
2,475
|
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
Accrued salaries and wages
|
$
|
2,698
|
|
|
$
|
3,418
|
|
|
Accrued vacation
|
2,348
|
|
|
2,232
|
|
||
|
Accrued bonuses
|
2,417
|
|
|
4,258
|
|
||
|
Warranty accrual
|
1,561
|
|
|
1,556
|
|
||
|
Stock rotation accrual
|
1,778
|
|
|
2,032
|
|
||
|
Accrued professional fees
|
905
|
|
|
687
|
|
||
|
ESPP payable
|
779
|
|
|
313
|
|
||
|
Customer deposits
|
341
|
|
|
179
|
|
||
|
Other accrued expenses
|
5,743
|
|
|
6,351
|
|
||
|
|
$
|
18,570
|
|
|
$
|
21,026
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Beginning balance
|
$
|
1,556
|
|
|
$
|
664
|
|
|
Addition
|
118
|
|
|
260
|
|
||
|
Utilization
|
(113
|
)
|
|
(229
|
)
|
||
|
Ending balance
|
$
|
1,561
|
|
|
$
|
695
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Beginning balance
|
$
|
2,032
|
|
|
$
|
1,880
|
|
|
Addition
|
1,618
|
|
|
1,330
|
|
||
|
Utilization
|
(1,872
|
)
|
|
(1,917
|
)
|
||
|
Ending balance
|
$
|
1,778
|
|
|
$
|
1,293
|
|
|
Land
|
$
|
4,950
|
|
|
Building
|
3,900
|
|
|
|
Machinery and equipment
|
15,564
|
|
|
|
Inventories
|
2,159
|
|
|
|
Accrued liabilities
|
(512
|
)
|
|
|
Goodwill
|
269
|
|
|
|
Total purchase consideration
|
$
|
26,330
|
|
|
|
|
|
Weighted
|
|
|
|||||
|
|
|
|
Average
|
|
|
|||||
|
|
Number of
|
|
Exercise Price
|
|
Aggregate
|
|||||
|
|
Shares
|
|
Per Share
|
|
Intrinsic Value
|
|||||
|
Outstanding at June 30, 2012
|
4,214,652
|
|
|
$
|
10.00
|
|
|
$
|
6,758,645
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|||
|
Exercised
|
(127,441
|
)
|
|
2.95
|
|
|
$
|
762,591
|
|
|
|
Canceled or forfeited
|
(119,736
|
)
|
|
11.73
|
|
|
|
|||
|
Outstanding at September 30, 2012
|
3,967,475
|
|
|
$
|
10.18
|
|
|
$
|
5,211,558
|
|
|
|
Options Outstanding
|
|
Options Vested and Exercisable
|
||||||||||||
|
|
Number Outstanding
|
|
Weighted-Average
Remaining Contractual Life (years) |
|
Weighted-Average
Exercise Price |
|
Number Exercisable
|
|
Weighted-Average
Exercise Price |
||||||
|
Total options outstanding
|
3,967,475
|
|
|
5.42
|
|
$
|
10.18
|
|
|
2,948,758
|
|
|
$
|
9.32
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Options vested and expected to vest
|
3,883,442
|
|
|
5.36
|
|
$
|
10.12
|
|
|
|
|
|
|||
|
|
Number of Restricted Stock
Units
|
|
Weighted Average
Grant Date Fair
Value Per Share
|
|
Weighted Average
Remaining
Recognition
Period (Years)
|
|
Aggregate Intrinsic Value
|
|||||||
|
Nonvested at June 30, 2012
|
|
449,378
|
|
|
$
|
10.33
|
|
|
|
2.26
|
|
$
|
4,111,809
|
|
|
Granted
|
|
69,400
|
|
|
|
8.92
|
|
|
|
|
|
|
||
|
Vested
|
|
(23,812
|
)
|
|
|
9.51
|
|
|
|
|
|
|
||
|
Forfeited
|
|
(15,650
|
)
|
|
|
10.22
|
|
|
|
|
|
|
||
|
Nonvested at September 30, 2012
|
|
479,316
|
|
|
$
|
10.17
|
|
|
|
2.10
|
|
$
|
4,126,911
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
RSUs vested and expected to vest
|
|
420,626
|
|
|
|
|
|
|
1.99
|
|
$
|
3,621,589
|
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Cost of goods sold
|
$
|
198
|
|
|
$
|
81
|
|
|
Research and development expenses
|
393
|
|
|
259
|
|
||
|
Selling, general and administrative expenses
|
850
|
|
|
882
|
|
||
|
|
|
|
|
||||
|
|
$
|
1,441
|
|
|
$
|
1,222
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Hong Kong
|
$
|
74,627
|
|
|
$
|
64,852
|
|
|
China
|
17,629
|
|
|
14,622
|
|
||
|
South Korea
|
2,268
|
|
|
2,458
|
|
||
|
United States
|
343
|
|
|
401
|
|
||
|
Other countries
|
894
|
|
|
1,115
|
|
||
|
|
$
|
95,761
|
|
|
$
|
83,448
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Power discrete
|
$
|
75,504
|
|
|
$
|
63,714
|
|
|
Power IC
|
14,531
|
|
|
13,313
|
|
||
|
Packaging and testing services
|
5,726
|
|
|
6,421
|
|
||
|
|
$
|
95,761
|
|
|
$
|
83,448
|
|
|
|
September 30,
2012 |
|
June 30,
2012 |
||||
|
|
(in thousands)
|
||||||
|
China
|
$
|
109,393
|
|
|
$
|
111,432
|
|
|
United States
|
47,144
|
|
|
46,730
|
|
||
|
Other countries
|
473
|
|
|
381
|
|
||
|
|
$
|
157,010
|
|
|
$
|
158,543
|
|
|
|
Three Months Ended September 30,
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||
|
|
(in thousands)
|
|
(% of revenue)
|
||||||||||
|
Revenue
|
$
|
95,761
|
|
|
$
|
83,448
|
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of goods sold
|
70,228
|
|
|
62,871
|
|
|
73.3
|
%
|
|
75.3
|
%
|
||
|
Gross profit
|
25,533
|
|
|
20,577
|
|
|
26.7
|
%
|
|
24.7
|
%
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
6,933
|
|
|
8,394
|
|
|
7.2
|
%
|
|
10.1
|
%
|
||
|
Selling, general and administrative
|
8,781
|
|
|
9,283
|
|
|
9.2
|
%
|
|
11.1
|
%
|
||
|
Total operating expenses
|
15,714
|
|
|
17,677
|
|
|
16.4
|
%
|
|
21.2
|
%
|
||
|
Operating income
|
9,819
|
|
|
2,900
|
|
|
10.3
|
%
|
|
3.5
|
%
|
||
|
Interest income
|
17
|
|
|
39
|
|
|
—
|
%
|
|
—
|
%
|
||
|
Interest expense
|
(82
|
)
|
|
(27
|
)
|
|
(0.1
|
)%
|
|
—
|
%
|
||
|
Income before income taxes
|
9,754
|
|
|
2,912
|
|
|
10.2
|
%
|
|
3.5
|
%
|
||
|
Income tax expense
|
1,812
|
|
|
773
|
|
|
1.9
|
%
|
|
0.9
|
%
|
||
|
Net income
|
$
|
7,942
|
|
|
$
|
2,139
|
|
|
8.3
|
%
|
|
2.6
|
%
|
|
|
Three Months Ended September 30,
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||
|
|
(in thousands)
|
|
(% of revenue)
|
||||||||||
|
Cost of goods sold
|
$
|
198
|
|
|
$
|
81
|
|
|
0.2
|
%
|
|
0.1
|
%
|
|
Research and development expenses
|
393
|
|
|
259
|
|
|
0.4
|
%
|
|
0.3
|
%
|
||
|
Selling, general and administrative expenses
|
850
|
|
|
882
|
|
|
0.9
|
%
|
|
1.1
|
%
|
||
|
Total
|
$
|
1,441
|
|
|
$
|
1,222
|
|
|
1.5
|
%
|
|
1.5
|
%
|
|
|
Three Months Ended September 30,
|
|||||||||||||
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
|
|
(in thousands)
|
|
(in thousands)
|
|
(in percentage)
|
|||||||||
|
Power discrete
|
$
|
75,504
|
|
|
$
|
63,714
|
|
|
$
|
11,790
|
|
|
18.5
|
%
|
|
Power IC
|
14,531
|
|
|
13,313
|
|
|
1,218
|
|
|
9.1
|
%
|
|||
|
Packaging and testing services
|
5,726
|
|
|
6,421
|
|
|
(695
|
)
|
|
(10.8
|
)%
|
|||
|
|
$
|
95,761
|
|
|
$
|
83,448
|
|
|
$
|
12,313
|
|
|
14.8
|
%
|
|
|
Three Months Ended September 30,
|
|||||||||||||
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
|
|
(in thousands)
|
|
(in thousands)
|
|
(in percentage)
|
|||||||||
|
Cost of goods sold
|
$
|
70,228
|
|
|
$
|
62,871
|
|
|
$
|
7,357
|
|
|
11.7
|
%
|
|
Percentage of revenue
|
73.3
|
%
|
|
75.3
|
%
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||
|
Gross profit
|
$
|
25,533
|
|
|
$
|
20,577
|
|
|
$
|
4,956
|
|
|
24.1
|
%
|
|
Percentage of revenue
|
26.7
|
%
|
|
24.7
|
%
|
|
|
|
|
|||||
|
|
Three Months Ended September 30,
|
|||||||||||||
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
|
|
(in thousands)
|
|
(in thousands)
|
|
(in percentage)
|
|||||||||
|
Research and development
|
$
|
6,933
|
|
|
$
|
8,394
|
|
|
$
|
(1,461
|
)
|
|
(17.4
|
)%
|
|
|
Three Months Ended September 30,
|
|||||||||||||
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
|
|
(in thousands)
|
|
(in thousands)
|
|
(in percentage)
|
|||||||||
|
Selling, general and administrative expenses
|
$
|
8,781
|
|
|
$
|
9,283
|
|
|
$
|
(502
|
)
|
|
(5.4
|
)%
|
|
|
Three Months Ended September 30,
|
|||||||||||||
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
|
|
(in thousands)
|
|
(in thousands)
|
|
(in percentage)
|
|||||||||
|
Income tax expense
|
$
|
1,812
|
|
|
$
|
773
|
|
|
$
|
1,039
|
|
|
134.4
|
%
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(in thousands)
|
||||||
|
Net cash provided by operating activities
|
$
|
23,610
|
|
|
$
|
11,941
|
|
|
Net cash used in investing activities
|
(10,246
|
)
|
|
(12,652
|
)
|
||
|
Net cash provided by (used in) financing activities
|
(339
|
)
|
|
2,409
|
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
7
|
|
|
(6
|
)
|
||
|
|
|
|
|
||||
|
Net increase in cash and cash equivalents
|
$
|
13,032
|
|
|
$
|
1,692
|
|
|
|
|
|
|
||||
|
31.1
|
Certification of Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1*
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2*
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS**
|
XBRL Instance
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition
|
|
101.LAB**
|
XBRL Taxonomy Extension Labels
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation
|
|
ALPHA AND OMEGA SEMICONDUCTOR LIMITED
|
|
|
|
|
|
By:
|
/s/ MARY L. DOTZ
|
|
|
Mary L. Dotz
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|